Robert Hershberg
Chief Executive Officer at HILLEVAX, INC.
Net worth: 20 M $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
J. Wolchko | M | 53 | 17 years | |
William Rastetter | M | 75 | 15 years | |
Chad Robins | M | 49 | 15 years | |
Dean Li | M | 62 | 11 years | |
Blake Borgeson | M | 42 | 11 years | |
Paul S. Bavier | M | 51 | 3 years | |
John Mendlein | M | 64 | 17 years | |
Chistopher Gibson | M | 41 | 11 years | |
David Elkins | M | 55 | 6 years | |
Ramon Chavez Márquez | M | 60 | 4 years | |
Aditya Kohli | M | 36 | 3 years | |
Shane Maltbie | M | 42 | 3 years | |
Michelle Griffin | F | 58 | 7 years | |
Harlan Robins | M | 51 | 15 years | |
Julie Rubinstein | F | 52 | 13 years | |
Shefali Agarwal | M | 50 | 5 years | |
Karin Jooss | M | 59 | 5 years | |
Bahram Valamehr | M | 47 | 6 years | |
Robert Epstein | M | 69 | 10 years | |
Stacy Taylor | F | 64 | 5 years | |
Kyle Piskel | M | 40 | 3 years | |
Tina Larson | F | 49 | 6 years | |
Terry-Ann Burrell | F | 47 | 4 years | |
Yuan Xu | M | 56 | 3 years | |
Katey Owen | M | 55 | 3 years | |
Benjamin Mabey | M | 41 | 7 years | |
Hatfield Nathan | M | - | - | |
Gary Dubin | M | 67 | 2 years | |
Ian Peikon | M | - |
Cajal Neuroscience, Inc.
Cajal Neuroscience, Inc. BiotechnologyHealth Technology Cajal Neuroscience is a biotechnology company that focuses on discovering new treatments for neurodegeneration. The company is based in Seattle, WA and was founded by Ian Peikon. The company uses advanced technologies such as integrative human genetics, multi-omics, functional genomics, and microscopy to accelerate their target and drug discovery. | 4 years |
Kirk Malloy | M | 57 | 8 years | |
Mary Pat Lancelotta | F | - | - | |
Zavain Dar | M | 35 | 8 years | |
Edward Dulac | M | 49 | 4 years | |
Tim Coughlin | M | 57 | 11 years | |
Jeryl Hilleman | F | 66 | 3 years | |
Peter Neupert | M | 68 | 10 years | |
Elisha Finney | F | 62 | 7 years | |
Shelley Chu | M | 54 | 3 years | |
Patrick Heron | M | 53 | 4 years | |
Julie Gerberding | M | 69 | 3 years | |
Michael Pellini | M | 58 | 6 years | |
Teresa Foy | M | 60 | 2 years | |
Janet George | F | 57 | 3 years | |
Nanette Cocero | M | - | 1 years | |
Jaime Sepulveda | M | 70 | 3 years | |
Michael Lee | M | 45 | 6 years | |
Cindy Tahl | F | 51 | 15 years | |
Dana Rollison | M | 48 | 3 years | |
Zachary Bogue | M | 48 | 6 years | |
Karina Calzadilla | F | - | - | |
Ganesh Kumar Jagannathan | M | - | - | |
Zhou Yi | M | - | - | |
Mark A. Winham | M | - | 5 years | |
Gary F. Kohlwes | M | 87 |
UW Medicine
| - |
Richard Person | M | - | - | |
Michael Genin | M | - | - | |
Kristen Rushton | F | - | - | |
Kevin Leggat | M | - | - | |
Matthew Kinn | M | - | - | |
Paul Craig | M | - |
UW Medicine
| - |
Kimberly McNally | F | - |
UW Medicine
| - |
Jerome C. Bressi | M | - | 6 years | |
Julie Nordstrom | F | - |
UW Medicine
| - |
Jim Beitel | M | - | 7 years | |
Wen Bo Wang | M | - | 6 years | |
Laura Schaevitz | F | - | - | |
Ann Li Lee | M | 63 | 6 years | |
Peter Demopulos | M | 70 |
UW Medicine
| 35 years |
Nan Li | M | - | 8 years | |
Michael Secora | M | 41 | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jacqualyn Fouse | M | 62 | 7 years | |
Robert Hugin | M | 69 | 19 years | |
Wayne D. Burns | M | 67 | 10 years | |
R. Adams | M | 57 | 3 years | |
Chad Cohen | M | 49 | 7 years | |
Gregory R. Cox | M | 58 | 10 years | |
Amir Nashat | M | 51 | 13 years | |
David Socks | M | 49 | 3 years | |
Kenneth Bailey | M | 55 | 6 years | |
Mary Tedd Allen | M | 61 | 13 years | |
Timothy J. Smith | M | - | - | |
Peter Kellogg | M | 67 | 5 years | |
Thomas Daniel | M | 69 | 10 years | |
Richard B. Brewer | M | 72 | - | |
Christopher Henney | M | 83 | 12 years | |
Scott Smith | M | 61 | 10 years | |
Michael J. Kamdar | M | 57 |
VentiRx Pharmaceuticals, Inc.
VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | - |
Barney E. Saunders | M | 61 | 7 years | |
Julia Haller | M | 69 | - | |
Nicholas G. Galakatos | M | 66 | 10 years | |
James Johnson | M | 67 | 5 years | |
Martin Simonetti | M | 66 | 6 years | |
Lawrence V. Stein | M | 74 | 3 years | |
Michael Bonney | M | 65 | 4 years | |
Richard F. Hamm | M | 64 | 7 years | |
Susan B. Bayh | F | 64 | 12 years | |
Donald Kania | M | 69 | 3 years | |
John Weiland | M | 68 | 1 years | |
Patricia Hemingway Hall | F | 71 | 1 years | |
Thomas Perone | M | 59 | 12 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Hershberg
- Personal Network